Obinutuzumab in the treatment of autoimmune haemolytic anaemia and immune thrombocytopenia in patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma

被引:7
|
作者
Herishanu, Yair [1 ,2 ]
Levi, Shai [1 ]
Kamdjou, Talia [2 ]
Bornstein, Yotam [1 ]
Ram, Ron [1 ,2 ]
Benyamini, Noam [1 ]
Varon, David [1 ,3 ]
Avivi, Irit [1 ,2 ]
Perry, Chava [1 ,2 ]
机构
[1] Tel Aviv Sourasky Med Ctr, Dept Hematol, Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[3] Hadassah Hebrew Univ Med Ctr, Coagulat Unit, Jerusalem, Israel
关键词
obinutuzumab; AIHA; ITP; CLL; RITUXIMAB; EFFICACY; ADULTS; SAFETY; CLL;
D O I
10.1111/bjh.17105
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E1 / E4
页数:4
相关论文
共 50 条
  • [41] A phase II trial of eltrombopag for patients with chronic lymphocytic leukaemia (CLL) and thrombocytopenia
    Paul, Shilpa
    Jain, Nitin
    Ferrajoli, Alessandra
    O'Brien, Susan
    Burger, Jan
    Keating, Michael
    Wierda, William
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (03) : 606 - 608
  • [42] Treatment Patterns, Healthcare Resource Utilization, and Costs of Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in the US
    Yang, Xiaoqin
    Zanardo, Enrico
    Lejeune, Dominique
    De Nigris, Enrico
    Sarpong, Eric
    Farooqui, Mohammed
    Laliberte, Francois
    ONCOLOGIST, 2024, 29 (03) : E360 - E371
  • [43] Other Malignancies in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
    Tsimberidou, Apostolia-Maria
    Wen, Sijin
    McLaughlin, Peter
    O'Brien, Susan
    Wierda, William G.
    Lerner, Susan
    Strom, Sara
    Freireich, Emil J.
    Medeiros, L. Jeffrey
    Kantarjian, Hagop M.
    Keating, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (06) : 904 - 910
  • [44] Proapoptotic and immunomodulatory effects of SYK inhibitor entospletinib in combination with obinutuzumab in patients with chronic lymphocytic leukaemia
    Lam, Vi
    Best, Scott
    Kittai, Adam
    Orand, Kirsten
    Spurgeon, Stephen E.
    Liu, Tingting
    Danilov, Alexey V.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (02) : 836 - 841
  • [45] Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma With Pancytopenia and Chylothorax
    Thomas, Lisa C.
    Maida, Matthew J.
    Martinez-Outschoorn, Ubaldo
    Filicko-O'Hara, Joanne
    Morris, Gloria J.
    SEMINARS IN ONCOLOGY, 2011, 38 (02) : 165 - 170
  • [46] Romiplostim for chronic lymphocytic leukemia-associated immune thrombocytopenia
    D'Arena, Giovanni
    Cascavilla, Nicola
    LEUKEMIA & LYMPHOMA, 2011, 52 (04) : 701 - 704
  • [47] Rituximab in Lymphoma and Chronic Lymphocytic Leukaemia: A Practice Guideline
    Prica, A.
    Baldassarre, F.
    Hicks, L. K.
    Imrie, K.
    Kouroukis, T.
    Cheung, M.
    CLINICAL ONCOLOGY, 2017, 29 (01) : E13 - E28
  • [48] Prolonged methylprednisolone premedication prior to obinutuzumab in patients with chronic lymphocytic leukemia
    Pejsa, Vlatko
    Lucijanic, Marko
    Vuk, Anamarija Vrkljan
    Stoos-Veic, Tajana
    Jaksic, Ozren
    Jonjic, Zeljko
    Pirsic, Mario
    Prka, Zeljko
    Ivic, Marija
    Dzankic, Amina Fazlic
    Mitrovic, Zdravko
    LEUKEMIA & LYMPHOMA, 2020, 61 (04) : 934 - 939
  • [49] Acalabrutinib, venetoclax, and obinutuzumab as frontline treatment for chronic lymphocytic leukaemia: a single-arm,-label, 2
    Davids, Matthew S.
    Lampson, Benjamin L.
    Tyekucheva, Svitlana
    Wang, Zixu
    Lowney, Jessica C.
    Pazienza, Samantha
    Montegaard, Josie
    Patterson, Victoria
    Weinstock, Matthew
    Crombie, Jennifer L.
    Ng, Samuel Y.
    Kim, Austin, I
    Jacobson, Caron A.
    LaCasce, Ann S.
    Armand, Philippe
    Arnason, Jon E.
    Fisher, David C.
    Brown, Jennifer R.
    LANCET ONCOLOGY, 2021, 22 (10) : 1391 - 1402
  • [50] A phase II study of induction followed by intermittent duvelisib dosing in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
    Shouse, Geoffrey
    Chen, Lu
    Siddiqi, Tanya
    Muir, Alex
    Brown, Jennifer R.
    Spurgeon, Stephen E.
    Danilov, Alexey V.
    LEUKEMIA & LYMPHOMA, 2024, 65 (10) : 1516 - 1519